Back to Search
RICHARD BIANCO, D.M.D
D.M.D
Dentist
NPI: 1902925241Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
43116(CA)
Research & Publications (20)
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.
PMID 18694994·Clin Cancer Res·2008
8-other
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs.
PMID 18319715·Br J Cancer·2008
7-preclinical
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling.
PMID 18045190·Curr Pharm Des·2007
6-review
Rational bases for the development of EGFR inhibitors for cancer treatment.
PMID 17596994·Int J Biochem Cell Biol·2007
6-review
Combination of biological therapies in non-small cell lung cancer.
PMID 16608984·Ann Oncol·2006
6-review
Key cancer cell signal transduction pathways as therapeutic targets.
PMID 16376541·Eur J Cancer·2006
6-review
Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy.
PMID 16113092·Endocr Relat Cancer·2005
6-review
Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years.
PMID 15721435·Gynecol Oncol·2005
5-case
Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients.
PMID 15914850·J Gen Virol·2005
4-observational
Chemosensitization by antisense oligonucleotides targeting MDM2.
PMID 15720189·Curr Cancer Drug Targets·2005
6-review
Monoclonal antibodies targeting the epidermal growth factor receptor.
PMID 15857288·Curr Drug Targets·2005
6-review
Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
PMID 15269162·Clin Cancer Res·2004
4-observational
Untraditional methods for targeting the kidney in transgenic mice.
PMID 14600026·Am J Physiol Renal Physiol·2003
6-review
Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase.
PMID 19643090·Brain Res·2009
7-preclinical
Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis.
PMID 19660265·J Thorac Cardiovasc Surg·2009
5-case
Depth-dependent dissociation of nitric acid at an aqueous surface: Car-Parrinello molecular dynamics.
PMID 19173580·J Phys Chem A·2009
8-other
A novel alternative placement site and technique for totally implantable vascular access ports in non-human primates.
PMID 19220683·J Med Primatol·2009
7-preclinical
Infrared signatures of HNO3 and NO3(-) at a model aqueous surface. A theoretical study.
PMID 18714961·J Phys Chem A·2008
8-other
[Vacuum-assisted breast biopsy for diagnosis of non-palpable lesions: experience with 226 cases].
PMID 18841819·Pathologica·2008
8-other
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3.
PMID 18698039·Clin Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 82 MARIPOSA AVE
WATSONVILLE, CA 95076 - Phone
- (831) 722-3308
Quick Facts
- NPI
- 1902925241
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile